ARWR
Arrowhead Pharmaceuticals Inc
66.50$
-1.9%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -27.7% | -3.1% | -18.8% | +7.3% | +213.5% | +49.4% | +35.9% | -2.6% | +10.6% | +48.9% | +21.5% | |
| – | -33.5% | -12.0% | -25.0% | +16.0% | +236.7% | +21.5% | +19.3% | +5.4% | +3.5% | +65.8% | +36.7% | |
| – | -38.7% | +5.1% | -70.9% | +21.3% | +636.1% | -35.3% | +28.5% | -41.4% | +2.7% | -7.4% | +120.6% | |
| – | -35.9% | -13.6% | -23.1% | +16.7% | +238.0% | +22.0% | +16.6% | +2.3% | +7.2% | +68.7% | +35.0% | |
| – | +0.0% | +0.0% | -9.6% | +382.9% | +102.0% | +27.9% | +1,112.6% | -86.3% | -100.0% | – | – | |
| – | – | – | -32.8% | +46.2% | +161.7% | +28.1% | +2.6% | -595.5% | – | – | – | |
| – | +16.9% | +239.9% | +0.8% | -10.2% | +66.6% | +33.0% | +57.6% | +126.6% | +204.2% | – | – | |
| – | +2,349.4% | -10.7% | -7.7% | -8.3% | -9.1% | -10.0% | – | – | – | – | – | |
| – | +2,349.4% | -10.7% | -7.7% | -8.3% | -9.1% | -10.0% | -11.1% | -12.4% | -14.2% | -16.6% | -19.9% | |
| – | +34.5% | +46.4% | -30.2% | -29.3% | +546.4% | -42.6% | +396.2% | -9.2% | +74.9% | +98.3% | -7.0% | |
| – | +34.2% | +61.3% | -27.1% | -33.9% | +685.0% | -58.1% | +260.2% | -5.2% | -24.1% | -2.2% | +89.5% | |
| – | -17.6% | -10.7% | +7.3% | +7.3% | +5,098.2% | -90.6% | +105.5% | +23.4% | +280.5% | -40.0% | +645.6% | |
| – | +95.1% | +143.1% | -66.7% | -31.2% | +172.6% | -10.7% | +38.5% | -69.7% | +1,150.6% | -68.2% | +55.2% | |
| – | -28.6% | +368.3% | -8.2% | -9.6% | – | – | – | – | – | – | -45.3% | |
| – | -33.8% | -13.2% | -14.8% | +17.7% | +155.3% | +88.8% | -11.5% | -2.5% | -31.9% | -31.7% | +151.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +22.2% | +6.4% | +21.0% | +13.2% | +17.9% | +2.1% | +3.0% | +1.6% | +1.3% | +12.2% | +11.7% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.